These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28483734)

  • 1. Leishmaniasis of the Feet Sole: A Case Report.
    Ayatollahi J; Bafghi AF; Shahcheraghi SH
    Turkiye Parazitol Derg; 2017 Mar; 41(1):48-49. PubMed ID: 28483734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.
    Mohammadzadeh M; Behnaz F; Golshan Z
    J Infect Public Health; 2013 Apr; 6(2):120-4. PubMed ID: 23537825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symmetrical cutaneous leishmaniasis.
    Guarneri C; Guarneri F
    Acta Derm Venereol; 2005; 85(3):281-2. PubMed ID: 16040429
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sporotrichoid cutaneous leishmaniasis].
    López-Escobar M; Drake-Monfort M; Salesa-Gutiérrez de Rozas R; Hermana-Ramírez S
    Actas Dermosifiliogr; 2007; 98(6):444-5. PubMed ID: 17663940
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous lupoid leishmaniasis: a case report.
    Ferahbaş A; Mistik S; Utaş S; Yaman O; Canoz O; Doganay M; Aşçioglu O
    Cutis; 2006 Jan; 77(1):25-8; quiz 37-8. PubMed ID: 16475491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
    Salmanpour R; Razmavar MR; Abtahi N
    Int J Dermatol; 2006 Sep; 45(9):1115-6. PubMed ID: 16961529
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z; Nakhli A; Rassaii S
    Int J Dermatol; 2005 Dec; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens].
    Aydın Teke T; Metin Timur Ö; Gayretli Aydın ZG; Öz N; Bayhan Gİ; Yılmaz N; Mungan M; Tanır G
    Turkiye Parazitol Derg; 2015 Jun; 39(2):147-50. PubMed ID: 26081889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Layegh P; Yazdanpanah MJ; Vosugh EM; Pezeshkpoor F; Shakeri MT; Moghiman T
    Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Leishmaniasis of the Eyelids: A Case Series with Molecular Identification and Literature Review.
    Mohammadpour I; Motazedian MH; Handjani F; Hatam GR
    Korean J Parasitol; 2016 Dec; 54(6):787-792. PubMed ID: 28095664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated American cutaneous leishmaniasis.
    Bonfante-Garrido R; Barroeta S; de Alejos MA; Meléndez E; Torrealba J; Valdivia O; Momen H; Grimaldi Júnior G
    Int J Dermatol; 1996 Aug; 35(8):561-5. PubMed ID: 8854152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran.
    Zerehsaz F; Salmanpour R; Handjani F; Ardehali S; Panjehshahin MR; Tabei SZ; Tabatabaee HR
    Int J Dermatol; 1999 Aug; 38(8):610-2. PubMed ID: 10487453
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
    Bogenrieder T; Lehn N; Landthaler M; Stolz W
    Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intralesional treatment of cutaneous leishmaniasis: a report of two cases].
    Clarós P; Wienberg P; González MA; Clarós A; Clavería MA; López P
    Acta Otorrinolaringol Esp; 1996; 47(1):67-70. PubMed ID: 8645493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postkala-azar dermal leishmaniasis].
    de Juan Martín F; Justa Roldán ML; Sáez de Adana Pérez E; Navarro Serrano E; Bouthelier Moreno M; Gilaberte Calzada Y; Fortuño Cebamanos B
    An Esp Pediatr; 1997 Jan; 46(1):63-4. PubMed ID: 9082890
    [No Abstract]   [Full Text] [Related]  

  • 16. Responses of Leishmania (Viannia) braziliensis cutaneous infection to N-methylglucamine antimoniate in the rhesus monkey (Macaca mulatta) model.
    Teva A; Porrozzi R; Oliveira-Neto MP; Grimaldi GJ
    J Parasitol; 2005 Aug; 91(4):976-8. PubMed ID: 17089782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S; Javadi A; Dabiri S; Shamsi Meymandi M; Nadji M
    Arch Iran Med; 2011 Jul; 14(4):238-43. PubMed ID: 21726098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic facial ulceration in France and potential involvement of Leishmania infantum cutaneous leishmaniasis].
    Lenvers P; Marty P; Peyron F
    Ann Dermatol Venereol; 2013 Nov; 140(11):704-7. PubMed ID: 24206806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of erysipeloid cutaneous leishmaniasis: atypical and unusual clinical variant.
    Ceyhan AM; Yildirim M; Basak PY; Akkaya VB; Erturan I
    Am J Trop Med Hyg; 2008 Mar; 78(3):406-8. PubMed ID: 18337335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infiltrated leishmaniasis recidivans cutis on the face: a rare clinical presentation.
    Masood S; Naveed S; Alvi RU
    Trop Doct; 2012 Apr; 42(2):120-1. PubMed ID: 22337728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.